hedgefunds

Something to Watch

Filed in archive Investing on March 29, 2007

Interesting article here; Osiris Rises on Heart-Treatment News.

Investors bid up Osiris Therapeutics stock by 13.6% to $20.33 per share in early trading on the Nasdaq on March 26 after the company's stem cell treatment produced positive results in a clinical trial.

Something to Watch
When Osiris Therapeutics (OSIR) announced encouraging results from its effort to help the hundreds of thousands who die each year because their scarred hearts can no longer pump blood efficiently, investors bid up the Baltimore stem cell therapeutic company's stock on March 26.

Also up is Alexza Pharmaceuticals (ALXA) who announced encouraging results on Mar. 26 from two studies intended to develop new treatments for migraine victims and schizophrenic patients with acute agitation.

Investors bid up Alexza's stock by more than 52% to $15.21 per share on the Nasdaq March 26. Story here.

Good article in the Kingsland report.

Permalink: Something to Watch

Tags: hedge+fund  hedge  funds  fund  home  hedge+funds  something+watch 

Vote for Something to Watch:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Most Popular   Announcements   Best of   Cartoon   Charity   Companies and Markets   Dealtalk   Did you know   FAQ   Hedgetalk   Humor   Information About   Investing   Legal   Op-Ed   Quick introduction